Earlier this week, IBM announced that we would provide the IBM Clinical Development (ICD) system, free of charge to eligible institutions in China to assist in the battle against Coronavirus.
We will work together with medical institutions and practitioners to leverage ICD and support the accelerated development of key drugs to combat the virus. The system is designed to reduce the time and cost of clinical trials by centralizing and organizing clinical trial details, providing 24/7 access to clinical trial data via a single URL from any web-enabled device and providing a flexible and scalable data management platform.
As part of IBM’s plan to help support the accelerated development of key drugs to combat the coronavirus, IBM intends to:
provide ICD system free of charge to eligible applicable novel coronavirus-related clinical trials in China
provide commercially-reasonable technology free of charge to support database construction and basic training for the use of ICD.
For detailed product and service information, please see https://lnkd.in/ehv8WsS.